INTERVIEW: Robert Wessman On Growing Generics, And Why Biosimilars Will Dominate The Future

 
• By John Davis

Robert Wessman, executive chairman of the rapidly growing generics company Alvogen, talks about the future of the generics industry, how to build a global generics company, and founding the Icelandic biosimilars manufacturer, Alvotech.

SC1606_Wessman-and-friends_1200
Alvotech's New Facilities Opening Ceremony: Robert Wessman (center), Eef Schimmelpennink (right) and Fjalar Kristjansson (left). • Source: Alvotech.

More from Business

More from Scrip